<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Opportunistic screening for undiagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and pre-<z:mp ids='MP_0002055'>diabetes</z:mp> (either <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> or impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>) is recommended by the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine efficient cutoff points for three screening tests for detecting undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> alone or both undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> and pre-<z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We estimated the number of individuals with undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> alone or with both undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> and pre-<z:mp ids='MP_0002055'>diabetes</z:mp> that could be detected by using different cutoff points for each screening test as the product of the prevalence of each condition, the sensitivity of the tests at each cutoff point for identifying each condition, and the number of individuals who would be eligible for screening in the U.S </plain></SENT>
<SENT sid="3" pm="."><plain>We estimated the total cost of opportunistic screening by multiplying the cost for screening one person by the number of individuals screened </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The most efficient cutoff points for both detecting pre-<z:mp ids='MP_0002055'>diabetes</z:mp> and undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> (100 mg/dl for the fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> test, 5.0% for the HbA(1c) test, and 100 mg/dl for the random capillary blood <z:chebi fb="105" ids="17234">glucose</z:chebi> test) were less than those for detecting undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> alone (110 mg/dl for the fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> test, 5.7% for the HbA(1c) test, and 120 mg/dl for the random capillary blood <z:chebi fb="105" ids="17234">glucose</z:chebi> test) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: A lower cutoff value should be used when screening for pre-<z:mp ids='MP_0002055'>diabetes</z:mp> and undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> together than when screening for undiagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> alone </plain></SENT>
</text></document>